Several critical questions remain unresolved, including the precise physiological and pathological role of TFPI2 in both malignant and non-malignant conditions, the identity of non-cancerous cells that modulate TFPI2 expression, the underlying regulatory mechanisms, and the exact influence of TFPI2 on cancer prognosis. The gene discussed is TFPI2; the disease is cancer.